Literature DB >> 7637231

[A successful case report of conservative treatment of MRSA empyema after right pneumonectomy].

D Kondo1, Y Kita.   

Abstract

We have successfully treated MRSA empyema after right pneumonectomy by the closed drainage and irrigation alone. The patient was a 70-year-old male who had received right pneumonectomy for p-III a squamous cell carcinoma originating in the right upper lobe bronchus. The operation wound was infected on the 6th postoperative day and became pleural fistula and finally MRSA empyema was developed on the 10th postoperative day. The chest drainage and irrigation of the infected pneumonectomy space with physiological saline containing antiseptic povidone iodine (Isodine) were performed 3 times a day for 14 days, however, the empyema was not cured completely. In addition, nausea and vomiting considered as the side effect of Isodine severely appeared. Therefore the antiseptic agent was exchanged to vancomycin hydrochloride from povidone iodine. Empyema space became sterile 4 days after the exchange and the drainage tube was removed 7 days after sterilization. Further empyema has not been developed for 8 months. We discussed the method and antiseptic agents in irrigation of empyema space.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7637231

Source DB:  PubMed          Journal:  Kyobu Geka        ISSN: 0021-5252


  2 in total

1.  Intrathoracic irrigation with arbekacin for methicillin-resistant Staphylococcus aureus empyema following lung resection.

Authors:  Tsuyoshi Ueno; Shinichi Toyooka; Junichi Soh; Kentaroh Miyoshi; Seiichiro Sugimoto; Masaomi Yamane; Takahiro Oto; Shinichiro Miyoshi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-06-20

2.  Surgical treatment of empyema after pulmonary resection using pedicle skeletal muscle plombage, thoracoplasty, and continuous cavity ablution procedures: a report on three cases.

Authors:  Noriaki Sakakura; Tetsuya Mizuno; Hiroaki Kuroda; Yukinori Sakao; Tatsuo Uchida
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.